(Q35329355)

7 August 2017

1 reference

title

Appetite suppressants. A review (English)

1 reference

7 August 2017

1 reference

T. Silverstone

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1379155

20 September 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1379155

20 September 2022

publication date

1 June 1992

1 reference

7 August 2017

1 reference

7 August 2017

43

1 reference

7 August 2017

820-836

1 reference

7 August 2017

6

1 reference

https://scigraph.springernature.com/pub.10.2165/00003495-199243060-00003

7 August 2017

0 references

cites work

Health implications of obesity. National Institutes of Health Consensus Development Conference Statement

1 reference

12 December 2020

Pharmacological treatment of obesity

1 reference

12 December 2020

A comparative trial of fenfluramine and diethylpropion inbesity

1 reference

12 December 2020

Plasma phentermine levels, weight loss and side-effects

1 reference

12 December 2020

Subjective profile of phenylpropanolamine: absence of stimulant or euphorigenic effects at recommended dose levels.

1 reference

12 December 2020

Outpatient treatments of obesity: a comparison of methodology and clinical results

1 reference

12 December 2020

Progress in assessing the role of serotonin in the control of food intake

1 reference

12 December 2020

Obesity in diabetes. Some considerations on treatment

1 reference

12 December 2020

AN. 448 on critical flicker frequency and heart rate in man

1 reference

12 December 2020

The anorectic activity of fenfluramine

1 reference

12 December 2020

Fluoxetine-induced weight loss in overweight non-depressed humans

1 reference

12 December 2020

Reinforcing and subjective effects of several anorectics in normal human volunteers.

1 reference

12 December 2020

Effects of two slimming drugs on sleep.

1 reference

12 December 2020

Plasma fenfluramine levels, weight loss and side effects: a failure to find a relationship

1 reference

12 December 2020

EEG profiles of fenfluramine, amobarbital and dextroamphetamine in normal volunteers

1 reference

12 December 2020

The effect of the 5-HT re-uptake inhibitor fluoxetine on food intake and body weight in healthy male subjects

1 reference

12 December 2020

Use of fluoxetine, a selective serotonin-uptake inhibitor, in the treatment of obesity: a dose-response study (with a commentary by Michael Weintraub)

1 reference

12 December 2020

Direct measurement of the anorectic activity of diethylpropion (Tenuate Dospan).

1 reference

12 December 2020

Double-blind cross-over evaluation of mazindol in the treatment of obese hypertensive patients

1 reference

12 December 2020

Subjective effects of two anorexigenic agents--fenfluramine and AN 448 in normal subjects

1 reference

12 December 2020

Safety of fluoxetine in the treatment of obesity

1 reference

12 December 2020

Central receptors and recognition sites mediating the effects of monoamines and anorectic drugs on feeding behavior

1 reference

12 December 2020

Phentermine resin as an adjunct in medical weight reduction: a controlled, randomized, double-blind prospective study

1 reference

12 December 2020

Comparison of the effects of d-amphetamine and fenfluramine on hunger and food intake in man

1 reference

12 December 2020

Phenylpropanolamine: effects on subjective and cardiovascular variables at recommended over-the-counter dose levels.

1 reference

12 December 2020

Species differences in the kinetics and metabolism of fenfluramine isomers.

1 reference

12 December 2020

The anorectic effect of a long-acting preparation of phentermine (duromine)

1 reference

12 December 2020

The effect of long-term dexfenfluramine treatment on 24-hour energy expenditure in man. A double-blind placebo controlled study

1 reference

12 December 2020

Dexfenfluramine. Its place in weight control

1 reference

12 December 2020

Plasma fenfluramine levels, weight loss, and side effects

1 reference

12 December 2020

Determinants of the pressor effect of phenylpropanolamine in healthy subjects

1 reference

12 December 2020

Extended-release fenfluramine: patient acceptance and efficacy of evening dosing

1 reference

12 December 2020

Fenfluramine in the treatment of obesity

1 reference

12 December 2020

A double-blind clinical evaluation of the anorectic activity of phenylpropanolamine versus placebo

1 reference

12 December 2020

Intermittent treatment with anorectic drugs

1 reference

12 December 2020

Dexfenfluramine. A review of its pharmacological properties and therapeutic potential in obesity

1 reference

12 December 2020

The role of serotonin in eating disorders

1 reference

12 December 2020

Clinical assessment of the use of an anorectic drug in a total weight reduction program

1 reference

12 December 2020

Prolonged use of a very low calorie diet (Cambridge diet) in massively obese patients attending an obesity clinic: safety, efficacy and additional benefit from dexfenfluramine

1 reference

12 December 2020

A comparison of the effects of d- and l-fenfluramine and d-amphetamine on energy and macronutrient intake in human subjects

1 reference

12 December 2020

Treatment of refractory obesity with fenfluramine

1 reference

12 December 2020

Subjective effects of two anorexigenic agents fenfluramine and AN 448 in amphetamine-dependent subjects

1 reference

12 December 2020

Diethylpropion hydrochloride: an effective appetite suppressant.

1 reference

12 December 2020

International trial of long-term dexfenfluramine in obesity.

1 reference

12 December 2020

The effect of phenylpropanolamine on ambulatory blood pressure

1 reference

12 December 2020

Treatment of obesity: comparison of physician and nonphysician therapists using placebo and anorectic drugs in a double-blind trial

1 reference

12 December 2020

Fenfluramine: study of its central action through its effects on sleep

1 reference

12 December 2020

Phenylpropanolamine OROS (Acutrim) vs. placebo in combination with caloric restriction and physician-managed behavior modification

1 reference

12 December 2020

A clinical trial of the efficacy and acceptability of D-fenfluramine in the treatment of neuroleptic-induced obesity.

1 reference

12 December 2020

Efficacy and safety of dexfenfluramine in obese patients: a multicenter study.

1 reference

12 December 2020

Differential effect of d-fenfluramine and metergoline on food intake in human subjects

1 reference

12 December 2020

A survey of patients' views on doctors' treatment of obesity

1 reference

12 December 2020

A comparative trial of different regimens of fenfluramine and phentermine in obesity

1 reference

12 December 2020

Sensitivity of the appetite control system in obese subjects to nutritional and serotoninergic challenges

1 reference

12 December 2020

Comparison of fenfluramine and metformin in treatment of obesity.

1 reference

12 December 2020

A controlled trial of phentermine in obese diabetic patients

1 reference

12 December 2020

Determinants of response to anorexiants.

1 reference

12 December 2020

Plasma concentrations of fenfluramine and its metabolite, norfenfluramine, after single and repeated oral administration

1 reference

12 December 2020

Three controlled trials of weight loss with phenylpropanolamine

1 reference

12 December 2020

Fenfluramine: a review of its pharmacological properties and therapeutic efficacy in obesity

1 reference

12 December 2020

Behavior therapy and pharmacotherapy for obesity

1 reference

12 December 2020

A double-blind, placebo-controlled trial of fluoxetine plus behavior modification in the treatment of obese binge-eaters and non-binge-eaters

1 reference

12 December 2020

Prolonged weight loss with dexfenfluramine treatment in obese patients.

1 reference

12 December 2020

Long-term use of diethylpropion in obesity

1 reference

12 December 2020

Anorectic drugs: drug policy making at the state level

1 reference

12 December 2020

10.2165/00003495-199243060-00003

Identifiers

DOI

1 reference

Dimensions Publication ID

7 August 2017

0 references

1 reference